Rite Aid has successfully defeated MedImpact Healthcare Systems in a $200 million dispute over the sale of its pharmacy benefit manager, Elixir. A judge ruled on Monday that MedImpact is not entitled to recoup the $200 million in extra costs, as it assumed Elixir's debts when it acquired the company. This ruling absolves Rite Aid of any responsibility for the additional costs tied to the recent acquisition.
MedImpact's attempt to recoup about $200 million related to its purchase of Rite Aid's pharmacy benefit unit failed after a judge ruled on Monday that it took on Elixir's debts when it bought the company. https://t.co/22fUnL8Mdb https://t.co/22fUnL8Mdb
Rite Aid defeats MedImpact in $200 million Elixir sale dispute https://t.co/ey9a9NKysg https://t.co/7cbuqVBZoa
MedImpact's attempt to recoup about $200 million related to its purchase of Rite Aid's pharmacy benefit unit failed after a judge ruled that it took on Elixir's debts when it bought the company https://t.co/jWA65Tyqa7 https://t.co/xqtytF9vxo
🔵 RITE AID DEFEATS MEDIMPACT IN $200 MILLION ELIXIR SALE DISPUTE MedImpact's attempt to recoup about $200 million related to its purchase of Rite Aid's pharmacy benefit unit failed after a judge ruled on Monday that it took on Elixir's debts when it bought the company. Full… https://t.co/JfTdC6lWP3
Rite Aid isn’t responsible for more than $200 million in extra costs tied to the recent acquisition of its pharmacy benefit manager Elixir by MedImpact Healthcare Systems, a judge ruled Monday https://t.co/703B8cmKwU
Prescription drug shortages are running at decades high levels. Don’t be caught unprepared or reliant on a broken system. Stockpile critical prescription medications with The Wellness Company’s medical emergency kit. Go to https://t.co/IvGXxC4be0 and order today. Use the promo…
Rite Aid and MedImpact are fighting over which company is responsible for more than $200 million in extra costs connected with an acquisition https://t.co/D4fFStddsW